Patients in Massachusetts may soon be receiving “farmacy” prescriptions in lieu of traditional pharmacy scripts.

A large-scale study published in the Journal of Hypertension Jan. 20 suggests the calcium channel blocker amlodipine can lower hypertensive patients’ BP while simultaneously minimizing their long-term risk of developing gout.

In just eight years, the world’s first completely robotic “hybrid” heart will be ready for transplant, according to the Daily Mail.

The Mediterranean diet has been eclipsed as the U.S. News & World Report’s best-ranked heart-healthy diet for the first time in a decade, nudged out of the top spot by the popular Ornish diet.

Berlin-based CV tech company Biotronik has hired cardiologist David Hayes, MD, as its first chief medical officer, the company announced Jan. 27.

Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.

The FDA has approved a Medtronic-run trial, PULSED AF, to evaluate the safety and efficacy of new tech that uses pulsed electric fields to treat AFib.

Burnout may increase a person’s risk of developing atrial fibrillation by as much as 20%, researchers reported this month in the European Journal of Preventive Cardiology.

A possible shortage of heparin, one of the most popular blood thinners on the market, is threatening the U.S., according to a viewpoint published in The Lancet on Jan. 23.

A simple ECG score could help physicians estimate infarct size in patients with prior MI, according to work published Jan. 24 in the Journal of the American Heart Association.